Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 4Unknown 3Withdrawn 2Terminated 2Recruiting 2Suspended 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Genitourinary 1Classical hematology 1

Conditions

Urinary Bladder Neoplasms 1Transfusion Reaction 1Anemia 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 290Drug Therapy 276Bevacizumab 248apatinib 247camrelizumab 219Etoposide 201Irinotecan 182Doxorubicin 181Leucovorin 163Dexamethasone 161pembrolizumab 153Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Blood Transfusion × Clear all
NCT05590429 2022-10-21

Blood Transfusion in Patients With Lung Cancer

Karadeniz Technical University

Unknown
400 enrolled

Transfusion Reaction

NCT04537221 2020-11-25

NorCys-Transf

Turku University Hospital

Unknown
1,700 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT01648946 2012-11-06

TRICCOP

Instituto do Cancer do Estado de São Paulo

Phase 3 Unknown
300 enrolled
Classical hematology

Anemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡